Capture was step one. Execution is step two.

Electronic data capture transformed clinical trials, but capture alone does not move a trial forward. Data can be recorded perfectly and still leave the most important question unanswered: what happens next?

Paper binders gave way to structured data, and information that once moved slowly across sites and sponsors became accessible in near real time. Systems such as EDC, eCOA, ePRO, and other capture platforms solved one of the industry’s most persistent challenges: reliably collecting clinical observations at scale.

Electronic capture solved the problem of collecting trial data. The next challenge is activating that data so it can drive decisions.

Trials do not advance simply because data exists. They advance because someone interprets that data and decides what should happen next. A protocol deviation must be classified. An anomaly must be investigated. A potential safety concern may need escalation. Capture systems record these events faithfully, but determining their meaning and deciding how the trial should respond requires a different kind of work.

The natural boundary of capture systems

Capture platforms are designed to solve a very specific and very important problem: recording observations with integrity. Systems such as EDC, eCOA, ePRO, and imaging platforms ensure that clinical information enters the trial in a structured, traceable, and auditable form. Their workflows support that mission by enabling data entry, query resolution, verification, and eventual record lock.

This shift to electronic capture fundamentally changed how trials operate, making information visible far more quickly across sites, sponsors, and CROs.

Yet the moment captured data requires interpretation, the purpose of the capture system begins to reach its natural boundary.

Consider what happens when a protocol deviation is recorded. The system has successfully captured the event and preserved the details. The next question, however, is not about recording information but about understanding it. Someone must determine whether the deviation is reportable, whether it affects patient safety or data integrity, and whether corrective action is required. Those determinations rarely belong to a single individual or a single system. They involve judgment, context, and coordination across roles.

A similar pattern emerges when unusual trends appear in trial data. Analytics may surface an anomaly, but the presence of the signal is only the beginning. Investigators, clinical operations teams, safety reviewers, and quality specialists may all need to contribute before a conclusion is reached.

At these moments, captured data stops being the destination and becomes the starting point. The work that follows involves interpreting what the information means and deciding how the trial should respond. That process often draws on multiple systems, multiple perspectives, and a sequence of coordinated steps beyond the original point of capture.

This is where handoffs begin to appear.

Where the real work begins

Once data is captured, the operational life of a trial unfolds around it. A deviation is recorded, an anomaly appears, or an unexpected pattern emerges in site performance. Each event represents a question the organization must answer.

Resolving that question rarely happens inside a single system. A clinical operations lead may review the issue, safety experts may evaluate potential risk, and quality teams may determine whether escalation or corrective action is necessary. If the issue proves significant, oversight committees or regulatory reporting processes may become involved.

Across these situations, a common pattern emerges. Captured data initiates a sequence of reviews, consultations, and decisions involving multiple roles and often multiple systems. Supporting documents may be retrieved from content repositories, analytics tools may provide additional context, and specialized systems may contribute relevant information.

As the issue progresses, responsibility passes from one group to another.

These transitions are the handoffs that carry a trial forward. Clinical operations may pass information to safety reviewers. Safety teams may involve quality specialists. Quality teams may escalate issues to governance committees. Each handoff represents a moment where context must travel with the information so that the next participant can understand the situation and contribute meaningfully.

In many organizations, these handoffs are managed through meetings, email threads, spreadsheets, and informal coordination. Experienced teams know how to navigate the process, but the workflow itself often remains implicit. The reasoning behind decisions may need to be reconstructed later if questions arise during oversight or inspection.

As trials generate increasing volumes of data, these moments become more frequent. More signals appear. More deviations are detected. More patterns require interpretation. Each initiates a journey that extends beyond the boundaries of the capture system.

Transactional workflows and decision workflows

The difference between capture systems and the work that follows becomes clearer when we examine the types of workflows they support.

Most capture platforms are built around transactional workflows. These workflows manage the movement of data and documents through predefined states inside a system. They govern activities such as entering data, resolving queries, verifying records, and locking entries once they are complete. Within those boundaries, they provide structure and consistency.

But the moments that move a trial forward rarely fit within those boundaries.

When a deviation must be classified, when a signal requires investigation, or when an anomaly raises questions about site performance, multiple participants must review information, apply judgment, and determine what should happen next.

This is where decision workflows begin.

Decision workflows span systems, roles, and organizations. They define who must review an issue, what information must be considered, how disagreements are resolved, and how outcomes are documented. They also govern the handoffs that move information from one participant to the next as the issue progresses.

Capture systems excel at transactional workflows. Running a trial, however, depends on decision workflows that extend well beyond the boundaries of any single platform.

The execution layer that orchestrates decisions

Once the distinction between transactional and decision workflows becomes clear, the next question follows naturally: how should those decision workflows be managed?

In many organizations they are not managed by a system at all. Coordination between observation and action often happens through informal processes that rely on meetings, email, and institutional knowledge. While experienced teams can make this work, the process itself remains difficult to scale as trials grow more complex.

This is where the execution layer becomes essential.

An execution layer orchestrates decision workflows across systems, roles, and organizations. Rather than relying on informal coordination, it defines the journey that issues follow from initial observation to final determination. It governs who participates at each stage, what information must be assembled before a decision can be made, and how outcomes are recorded.

In this environment, captured data becomes the starting point for a structured sequence of actions. When a deviation is recorded or an anomaly appears, the relevant context can be assembled and routed to the right reviewers. Different systems contribute their information at the appropriate moment, while participants engage with clarity about their role in the decision.

This orchestration allows captured information to become operational rather than isolated within the systems that recorded it.

From capture to execution

Clinical trial technology has always evolved in response to operational constraints.

The transition from paper to electronic capture solved a fundamental problem. Information that once moved slowly through binders and spreadsheets became structured, searchable, and accessible across organizations.

But as captured information has increased, the challenge has shifted. Trials now generate more signals than ever before, and each signal requires interpretation and response.

The capture system records the event. What determines the outcome is the sequence of decisions that follows.

This is why the next phase of clinical trial technology is not about capturing more data. It is about governing how decisions move once that data exists.

An execution layer provides that governance by orchestrating decision workflows across systems, roles, and organizations. Capture transformed how trials record what happened. Execution determines what happens next.

Want to see how an execution layer helps with decision workflows? Request a demo.

‍